Shield Therapeutics Plc shares rose +13.11% on 04 November 2026, according to the supplied market data, with (LSE:STX) attracting renewed investor attention.
Smith & Nephew plc shares climbed +6.49% on 04 November 2026, according to the supplied market data. The move places (LSE:SN.) among the top performers in the session.
The immediate context is shares rose 6.49% despite a reduction in full-year guidance. For Smith & Nephew, this matters because its exposure to orthopaedics and wound management creates a direct connection between theInvestmentnarrative and wider economic conditions. Market attention can increase sharply when investors …
Kooth PLC shares climbed +7.65% on 04 November 2026, according to the supplied market data. The move places (LSE:KOO) among the top performers in the session.
The wider market also offered support. The FTSE 100 rose 1.8% to 10,829.21 as the US midterm elections, which handed control of both chambers of Congress to the Democrats, boosted risk appetite. Healthcare policy in the United States is a major factor for ConvaTec, …
GSK's latest results, published on 28 October, showed solid momentum in specialty medicines but softerVaccinesales, and the shares slipped as investors noted the company kept rather than raised its guidance.
Investors are now weighing whether the selloff has gone too far given the resilience of the group's oral healthBusinessand its continued commitment to returning cash to shareholders.
The turnaround came as investors focused on a strategic disclosure tucked inside the update. Smith+Nephew confirmed that it had approached Johnson & Johnson earlier in the year about a possible combination between Johnson & Johnson's DePuy Synthes orthopaedicsBusinessand Smith+Nephew. The company also said it …
Attention on LSE:CRW remains elevated following its September results, which confirmed that growth had stalled. On the day of the release, the shares traded around £10.25 to £10.44, roughly 22% to 24% lower, valuing the company at about £354 million. The decline built on …
Convatec (LSE:CTEC) is a constituent of the FTSE All-Shareindexin the healthcare sector. It filed two board-related announcements today: "Chief Financial Officer succession" and "Director updates". We retrieved the first but not the second.